ProVen VCT (PVN) Share Price, News & Analysis

Company Overview

ProVen VCT plc is a venture capital trust specializing in emerging growth stage investment,expansion and management buyouts. The fund invests in small and medium sized smaller companies. It does not invest in startups. It seeks to invest in non-qualifying investments including cash, liquidity funds, fixed interest securities, debt and debt related securities in growth companies and non-qualifying venture capital investments. It invests in unquoted and AIM-listed companies and SMEs based in United Kingdom. Its holding period is from three to four years.

Key Stats

• Today's Range: 58 to 59.50
• 50-Day Range: 57 to 61
• 52-Week Range: 56.26 to 62.50
• Volume: 725 shs
• Average Volume: 153,330 shs
• Market Capitalization: £157.79 million
• P/E Ratio: 16.68
• Dividend Yield: 5.17%
• Price Target: N/A
• Consensus Rating: N/A

PVN Stock Analysis - Frequently Asked Questions

How have PVN shares performed this year?

ProVen VCT's stock was trading at GBX 58.50 at the beginning of the year. Since then, PVN stock has decreased by 0.9% and is now trading at GBX 58.

How were ProVen VCT's earnings last quarter?

ProVen VCT (LON:PVN) posted its earnings results on Monday, June, 9th. The company reported $0.20 earnings per share (EPS) for the quarter. ProVen VCT had a trailing twelve-month return on equity of 5.22% and a net margin of 67.04%.

How do I buy shares of ProVen VCT?

Shares of PVN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of ProVen VCT own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ProVen VCT investors own include AutoZone (AZO), Intel (INTC), TJX Companies (TJX), Abacus Health Products (ABAHF), Avino Silver & Gold Mines (ASM), Bank of America (BAC) and Cal-Maine Foods (CALM).

Company Calendar

• Last Earnings: 6/09/2025
• Today: 7/16/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Financial Services
• Industry: Asset Management
• Sub-Industry: N/A
• Current Symbol: LON:PVN
• CIK: N/A
• Web: www.provenvcts.co.uk
• Phone: +44-20-78457820
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): GBX 3.48
• Trailing P/E Ratio: 16.68
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £9.46 million
• Net Margins: 67.04%
• Pretax Margin: N/A
• Return on Equity: 5.22%
• Return on Assets: 3.12%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 40.74
• Quick Ratio: 66.08

Sales & Book Value

• Annual Sales: £14.11 million
• Price / Sales: 11.18
• Cash Flow: GBX 20.88 per share
• Price / Cash Flow: 2.78
• Book Value: GBX 66.83 per share
• Price / Book: 0.87

Miscellaneous

• Outstanding Shares: 272,057,000
• Free Float: N/A
• Market Cap: £157.79 million
• Optionable: Not Optionable
• Beta: 0.02